Rudi Ross

435 total citations
21 papers, 330 citations indexed

About

Rudi Ross is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rudi Ross has authored 21 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiation and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rudi Ross's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Advanced Radiotherapy Techniques (6 papers). Rudi Ross is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Advanced Radiotherapy Techniques (6 papers). Rudi Ross collaborates with scholars based in United States and Canada. Rudi Ross's co-authors include Sharon Salenius, Daniel E. Dosoretz, Michael J. Katin, Michelle H. Braccioforte, Brian J. Moran, Ming‐Hui Chen, Anthony V. D’Amico, Cary P. Gross, Timothy D. Shafman and James B. Yu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Rudi Ross

21 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rudi Ross United States	11	253	112	67	47	43	21	330
Amy Hayden Australia	10	268 1.1×	210 1.9×	99 1.5×	51 1.1×	110 2.6×	29	396
Christopher Straka United States	9	264 1.0×	174 1.6×	51 0.8×	36 0.8×	17 0.4×	12	368
Joseph P. Rodgers United States	10	163 0.6×	69 0.6×	30 0.4×	53 1.1×	33 0.8×	30	338
María Ángeles Cabeza Rodríguez Spain	6	290 1.1×	98 0.9×	39 0.6×	38 0.8×	40 0.9×	11	318
Nirdosh Kumar Gogna Australia	11	297 1.2×	116 1.0×	99 1.5×	104 2.2×	24 0.6×	13	430
E. Martinez Spain	9	242 1.0×	86 0.8×	26 0.4×	72 1.5×	21 0.5×	20	332
Juanita Crook Canada	7	390 1.5×	101 0.9×	28 0.4×	37 0.8×	28 0.7×	13	447
M. L. Vázquez de la Torre Spain	6	266 1.1×	92 0.8×	29 0.4×	22 0.5×	26 0.6×	12	283
Bao-Tian Huang China	10	168 0.7×	179 1.6×	171 2.6×	37 0.8×	43 1.0×	30	300
Elise De Bleser Belgium	10	179 0.7×	29 0.3×	63 0.9×	22 0.5×	29 0.7×	17	234

Countries citing papers authored by Rudi Ross

Since Specialization

Citations

This map shows the geographic impact of Rudi Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudi Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudi Ross more than expected).

Fields of papers citing papers by Rudi Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudi Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudi Ross. The network helps show where Rudi Ross may publish in the future.

Co-authorship network of co-authors of Rudi Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Rudi Ross. A scholar is included among the top collaborators of Rudi Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudi Ross. Rudi Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kann, Benjamin H., Vivek Verma, John M. Stahl, et al.. (2019). Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Radiotherapy and Oncology. 134. 44–49. 10 indexed citations

Ahamad, A., Paul E. Wallner, Sharon Salenius, Rudi Ross, & Eduardo Fernández. (2018). Information Needs Expressed During Patient-Oriented Oncology Consultations: Quantity, Variation, and Barriers. Journal of Cancer Education. 34(3). 488–497. 11 indexed citations

Kann, Benjamin H., Joseph A. Miccio, John M. Stahl, et al.. (2018). Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis. Radiotherapy and Oncology. 132. 188–196. 21 indexed citations

Ahamad, A., Álvaro Martínez, Sharon Salenius, et al.. (2017). Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers. Urologic Oncology Seminars and Original Investigations. 36(1). 9.e19–9.e25. 1 indexed citations

Hong, Julian C., Elham Rahimy, Cary P. Gross, et al.. (2017). Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Practical Radiation Oncology. 8(3). e79–e86. 33 indexed citations

Rahimy, Elham, Julian C. Hong, Cary P. Gross, et al.. (2017). Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(5). 1137–1145. 9 indexed citations

Ahamad, A., Paul E. Wallner, Sharon Salenius, Rudi Ross, & Eduardo Fernández. (2017). What do patients really want to know?. Journal of Clinical Oncology. 35(15_suppl). e18261–e18261. 3 indexed citations

Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. Radiotherapy and Oncology. 121(2). 294–298. 18 indexed citations

Stahl, John M., Rudi Ross, Eileen M. Harder, et al.. (2016). The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(5). 1011–1020. 30 indexed citations

10.

Parekh, Arti, Ming‐Hui Chen, Anthony V. D’Amico, et al.. (2013). Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy. 12(5). 415–421. 4 indexed citations

11.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2012). Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease. European Urology. 65(1). 177–185. 22 indexed citations

12.

Winkfield, Karen M., Ming‐Hui Chen, Daniel E. Dosoretz, et al.. (2011). Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate. International Journal of Radiation Oncology*Biology*Physics. 81(4). e345–e350. 9 indexed citations

13.

Nguyen, Paul L., Ming H. Chen, Toni K. Choueiri, et al.. (2010). Risk of All-Cause and Prostate Cancer–Specific Mortality After Brachytherapy in Men With Small Prostate Size. International Journal of Radiation Oncology*Biology*Physics. 79(5). 1318–1322. 8 indexed citations

14.

Hayes, Julia H., Ming‐Hui Chen, Brian J. Moran, et al.. (2010). Androgen‐suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke. British Journal of Urology. 106(7). 979–985. 19 indexed citations

15.

Nguyen, Paul L., Ming H. Chen, Samuel Z. Goldhaber, et al.. (2010). Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation. Cancer. 117(2). 406–413. 21 indexed citations

16.

Hoffman, Karen E., Ming‐Hui Chen, Brian J. Moran, et al.. (2010). Prostate cancer‐specific mortality and the extent of therapy in healthy elderly men with high‐risk prostate cancer. Cancer. 116(11). 2590–2595. 28 indexed citations

17.

Cheung, Arthur, Ming‐Hui Chen, Brian J. Moran, et al.. (2010). The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement. Brachytherapy. 9(2). 145–150. 3 indexed citations

18.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 77(1). 147–152. 11 indexed citations

19.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Total Androgen Blockade Versus a Luteinizing Hormone–Releasing Hormone Agonist Alone in Men With High-Risk Prostate Cancer Treated With Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1439–1444. 9 indexed citations

20.

D’Amico, Anthony V., Brian J. Moran, Michelle H. Braccioforte, et al.. (2009). Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease. Journal of Clinical Oncology. 27(24). 3923–3928. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact